OSI-027
-
Catalog number2372-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name4-(4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl)cyclohexanecarboxylic acid; ASP4786
-
DescriptionOSI-027 is a potent mammalian target of rapamycin (mTOR) kinase inhibitor with potential antineoplastic activity. It binds to and inhibits both the raptor-mTOR (TOR complex 1 or TORC1) and the rictor-mTOR (TOR complex 2 or TORC2) complexes of mTOR, which may result in tumor cell apoptosis and a decrease in tumor cell proliferation.
-
CAS Number936890-98-1
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₁H₂₂N₆O₃
-
Molecular Weight406.44
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~18 mg/ml)
-
HandlingProtect from light and moisture
-
Tag LineA potent mTOR inhibitor
-
Storage Condition-20 ̊C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD20275101
-
PubChem CID44224160
-
SMILESCOC1=CC=CC2=CC(=C3C4=C(N=CNN4C(=N3)C5CCC(CC5)C(=O)O)N)N=C21
-
InChiInChI=1S/C21H22N6O3/c1-30-15-4-2-3-13-9-14(25-16(13)15)17-18-19(22)23-10-24-27(18)20(26-17)11-5-7-12(8-6-11)21(28)29/h2-4,9-12H,5-8,22H2,1H3,(H,23,24)(H,28,29)/b17-14-
-
InChi KeyCDNMDRUIGNHEMR-VKAVYKQESA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameOSI-027
-
Alternative nameOSI-027
-